To educate participants on the treatment recommendations and goals for patients with anemia and chronic kidney disease. The session will begin with an overview of chronic kidney disease including delineation of stages, epidemiology, and complications. Particular focus will be on anemia in CKD – its causes, symptoms, diagnosis and treatment. The guidelines for managing anemia in CKD and available medications will be covered in detail. The discussion of treatment options will outline dosing, administration routes, warnings and contraindications, potential adverse effects, and monitoring. Participants will have an opportunity to review patient cases and select the appropriate treatment strategy for each.
Disclosures
Speaker: Indu Lew, PharmD; Vice President Corporate Pharmacy-Clinical Pharmacy Services,
RWJBarnabas Health, West Orange, NJ
Dr. Lew is on the speaker’s bureaus for American Regent and Amgen; presenter is also on the Advisory board of Novartis.
Reviewer: Darren Grabe, PharmD; Associate Professor of Pharmacy Practice, Albany College of Pharmacy; Adjunct Assistant Professor, Albany Medical College; Albany Nephrology Pharmacy Group, Albany, NY.
Dr. Grabe does not have any relevant financial relationships with any commercial interests.
Support for this activity:
- Educational grant funding was received from American Regent
American Health Resources assesses conflict of interest with its instructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. American Health Resources does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.